ACH
Accendra Health, Inc.
ACH trails on the overall score without a compensating advantage in the available component scores.
OSCR
Oscar Health, Inc.
OSCR has the edge over ACH overall, supported by stronger fundamentals.
ACH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
ACH's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
ACH PE Valuation
ACH has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
ACH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect ACH's earnings and profitability to decline, with its revenue holding steady.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over ACH on the outlook, with more favorable earnings and revenue expectations.
ACH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.24 | +$15.17 |
| Q2 2026 | -$3.93 | +$11.71 |
| Q1 2026 | -$14.07 | -$9.31 |
| Q4 2025 | -$14.31 | -$9.58 |
| Q3 2025 | -$17.41 | -$16.76 |
| Q2 2025 | -$15.64 | -$15.08 |
| Q1 2025 | -$4.76 | -$4.25 |
| Q4 2024 | -$4.73 | -$4.19 |
ACH is still losing money, but far less than before: $2.24 per share over the past year, against $17.41 at its worst in late 2025.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over ACH on earnings quality, reporting a profit while its opponent remains loss making.
ACH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $601.8M | -14% |
| Q2 2026 | $613.2M | -10% |
| Q1 2026 | $627.8M | -76% |
| Q4 2025 | $709M | -74% |
| Q3 2025 | $697.3M | -74% |
| Q2 2025 | $681.9M | -74% |
| Q1 2025 | $2.6B | +0.7% |
| Q4 2024 | $2.7B | +1.5% |
ACH's revenue has slid since its 2024 peak: $602M last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.2% | -3.6 points |
| Q2 2026 | -5.7% | +0.1 points |
| Q1 2026 | 2.7% | +2.7 points |
| Q4 2025 | 3% | +13 points |
| Q3 2025 | 3.8% | +2.9 points |
| Q2 2025 | -5.8% | -6.6 points |
| Q1 2025 | 0% | -0.4 points |
| Q4 2024 | -9.7% | -12 points |
ACH's operating margin was 0.2% last quarter, down 3.6 points from the same quarter a year ago.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over ACH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over ACH on profitability, with a higher operating margin.
ACH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$56.6M | +$170.2M |
| Q1 2026 | -$91.7M | -$56.7M |
| Q4 2025 | $55.1M | +574% |
| Q3 2025 | -$226.8M | -$192.6M |
| Q1 2025 | -$35.1M | +$63.9M |
| Q4 2024 | $8.2M | -87% |
| Q3 2024 | -$34.2M | -132% |
| Q2 2024 | $70.3M | -73% |
ACH has burned cash in six of the last eight quarters: −$167M over the past year, against −$288M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR has the edge over ACH on cash generation, producing positive trailing cash flow while its opponent burns cash.
ACH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +214K shares |
| 1 year | -0.5% | -379K shares |
| 3 years | +0.9% | +706K shares |
| 5 years | +1.3% | +951K shares |
| Available history | +27% | +16.3M shares |
ACH has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | $3.5M |
| Q3 2025 | — |
| Q2 2025 | $5.2M |
| Q1 2025 | $1.5M |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ACH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 8.6x | High |
| Q2 2026 | 6.8x | High |
| Q1 2026 | 7.4x | High |
| Q4 2025 | 8.0x | High |
| Q1 2025 | 54.7x | High |
| Q4 2024 | 31.7x | High |
| Q3 2024 | 4.8x | High |
| Q2 2024 | 4.6x | High |
ACH's net debt is about 8.6 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over ACH on leverage, with a lower net debt burden relative to earnings.
ACH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.1 | Oversold |
| Stochastic | 1.0 | Oversold |
ACH's weekly RSI is 24 (oversold) and its Stochastic is 1 (oversold).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
ACH PE vs Healthcare Sector
| Metric | ACH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ACH has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
ACH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.34 | 56% below |
| 20 week MA | $1.44 | 90% below |
| 50 week MA | $2.21 | 93% below |
| 100 week MA | $4.90 | 97% below |
| 200 week MA | $11.4 | 99% below |
ACH is in a downtrend: it's below all five of its weekly moving averages, and 99% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over ACH on trend strength, trading above more of its moving averages.
ACH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.08 | $30.3 | +497% |
| 2021 | $30.3 | $43.7 | +44% |
| 2022 | $43.7 | $19.5 | -55% |
| 2023 | $19.5 | $19.3 | -1% |
| 2024 | $19.3 | $13.0 | -33% |
| 2025 | $13.0 | $2.77 | -79% |
| 2026 YTD | $2.77 | $0.15 | -95% |
ACH has finished four years in a row lower, and it's down 95% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over ACH on returns for 2026, with the stronger performance.